Evidence map›Paper›PMID 26626729›Full record

ArticleBMC health services research2015

Excess length of stay and economic consequences of adverse events in Dutch hospital patients.

Janneke Hoogervorst-Schilp, Maaike Langelaan, Peter Spreeuwenberg, Martine C de Bruijne, Cordula Wagner

Registry-linked trialAbstract read
In one paragraph

Article in BMC health services research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04816968 (TAID Study - A Prospective Interventional Trial on Antibiotics Continuous Infusion at Home), which is not on this map. Cited by 37 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04816968 phase1unknown statusnot on this mapstarted 2021, after this paper: background citation

TAID Study - A Prospective Interventional Trial on Antibiotics Continuous Infusion at Home

TypeinterventionalSponsorOspedale San Carlo BorromeoRan2021 to 2023Enrolled50ConditionsSevere Bacterial InfectionsArmsCefepime, Piperacillin/tazobactam, Meropenem, Vancomycin
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Economic Burden of Stroke Disease: A Systematic Review.International journal of environmental research and public health · 2021
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Janneke Hoogervorst-SchilpNIVEL, Netherlands Institute for Health Services Research, PO Box 1568, 3500, BN, Utrecht, The Netherlands. jannekeschilp@hotmail.com.
Maaike LangelaanNIVEL, Netherlands Institute for Health Services Research, PO Box 1568, 3500, BN, Utrecht, The Netherlands. m.langelaan@nivel.nl.
Peter SpreeuwenbergNIVEL, Netherlands Institute for Health Services Research, PO Box 1568, 3500, BN, Utrecht, The Netherlands. p.spreeuwenberg@nivel.nl.
Martine C de BruijneDepartment of Public and Occupational Health & EMGO Institute for Health and Care Research, VU University Medical Centre, Van der Boechorststraat 7, 1081, BT, Amsterdam, The Netherlands. mc.debruyne@vumc.nl.
Cordula WagnerNIVEL, Netherlands Institute for Health Services Research, PO Box 1568, 3500, BN, Utrecht, The Netherlands. c.wagner@nivel.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate the average and extrapolated excess length of stay and direct costs of adverse events (AEs) and preventable AEs in Dutch hospitals, and to evaluate patient characteristics associated with excess length of stay and costs.

methodsData of a large retrospective patient record review study on AEs was used. A stratified sample of 20 Dutch hospitals was included. Excess length of stay and costs attributable to AEs and preventable AEs were calculated and extrapolated to a national estimate. The association between patient characteristics and excess length of stay (and costs thereof) attributable to AEs and preventable AEs was investigated through multilevel linear regression analyses.

resultsA total of 2975 patient records were included in the analysis, of which 325 experienced one or more AEs. Hospital patients experiencing an AE stayed 5.11 (95% CI 3.91-6.30) more days in hospital and cost €2600 (95% CI €1968-€3232) more compared to those without an AE. There was no significant difference in days and costs between preventable and non-preventable AEs. Extrapolated to a national level, AEs cost more than €300 million, which was 1.3% of the national hospital care budget. Patients with hospital-acquired infections had a statistically significant longer length of stay compared to the reference group (patients with AEs on the cardiovascular system).

conclusionsThis study showed that AEs lead to substantial excess length of stay and increased costs. Special attention should be paid to patients with AEs due to an hospital-acquired infection.

Indexed as

Hospital CostsInpatientsMedical ErrorsAdolescentAdultAgedChildChild, PreschoolCosts and Cost AnalysisFemaleHumansInfantLength of StayLinear ModelsMaleMedical Audit

Identifiers

PMID26626729
PMCPMC4667531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.